PROFROID
ActiveSummary
PROFROID has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €39,130 and a net result of €15,454. Equity is growing by ~60.6% per year across the filed fiscal years. Its solvency ranks better than 87% of 2,541 sector peers (NACE 85, fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
31-07
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial
Highest result since 2023net €15,454 ▲16.7%
Operating result €21,463, net result €15,454, both a record.
31-12
Financial
Liquidity doublescurrent ratio 7.26
Current ratio from 3.06 to 7.26; short-term debt falls from €11,036 to €6,146.
23-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
29-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 29 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 1 act read
About the unread acts
We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.